Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/251"

Predicate	Value (sorted: none)
rdf:type	?:Evidence
rdf:type	?:Item
rdfs:label	"evidence_1777"
?:Evidence_type	?:EV_PK_DDI_RCT
?:Evidence_assump_list_id	"48"
?:Evidence_enzyme_system	""
?:claim_assumed_valid_for_evidence_application_evidence_1777	?:triazolam_primary_total_clearance_enzyme_cyp3a4
dc:creator	"boycer"
dc:date	"10/22/2007 13:08:14"
?:content	"Route of administration: oral study duration: four phase crossover study; each phase consisted of four days pre-treatment with placebo or fluconazole (50,100, or 200mg), on day four 0.25mg of triazolam was administered population: 8 healthy adults male:3 female:5 ages: 20-32 AUC_i/AUC (0-inf): 50mg fluconazole = 1.63 100mg fluconazole = 2.05 200mg fluconazole = 4.42 description:"
rdfs:seeAlso	?:8904618

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ fluconazole_inhibits_cyp3a4, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1777 }

Context graph